CA948109A - Pharmaceutical compositions containing 2-(t-butylamino)-1-((4-hydroxy-3-hydroxymethyl)phenyl)ethanol and a 6,8-dialkyl-s-triazolo(4,3-a)pyrazine - Google Patents

Pharmaceutical compositions containing 2-(t-butylamino)-1-((4-hydroxy-3-hydroxymethyl)phenyl)ethanol and a 6,8-dialkyl-s-triazolo(4,3-a)pyrazine

Info

Publication number
CA948109A
CA948109A CA066,530A CA66530A CA948109A CA 948109 A CA948109 A CA 948109A CA 66530 A CA66530 A CA 66530A CA 948109 A CA948109 A CA 948109A
Authority
CA
Canada
Prior art keywords
triazolo
butylamino
pyrazine
dialkyl
hydroxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA066,530A
Other versions
CA66530S (en
Inventor
George E. Davies
Thomas P. Johnston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of CA948109A publication Critical patent/CA948109A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA066,530A 1968-12-10 1969-11-03 Pharmaceutical compositions containing 2-(t-butylamino)-1-((4-hydroxy-3-hydroxymethyl)phenyl)ethanol and a 6,8-dialkyl-s-triazolo(4,3-a)pyrazine Expired CA948109A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB58665/68A GB1235910A (en) 1968-12-10 1968-12-10 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CA948109A true CA948109A (en) 1974-05-28

Family

ID=10482136

Family Applications (1)

Application Number Title Priority Date Filing Date
CA066,530A Expired CA948109A (en) 1968-12-10 1969-11-03 Pharmaceutical compositions containing 2-(t-butylamino)-1-((4-hydroxy-3-hydroxymethyl)phenyl)ethanol and a 6,8-dialkyl-s-triazolo(4,3-a)pyrazine

Country Status (9)

Country Link
BE (1) BE742880A (en)
CA (1) CA948109A (en)
DE (1) DE1961967A1 (en)
FR (1) FR2025779B1 (en)
GB (1) GB1235910A (en)
IE (1) IE33837B1 (en)
IL (1) IL33328A (en)
NL (1) NL6916914A (en)
ZA (1) ZA697733B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1285834A (en) 1997-11-11 2001-02-28 小野药品工业株式会社 Fused pyrazine compound
WO1999025434A1 (en) * 1997-11-19 1999-05-27 Societe Emery S.A. Device for fixing a shell for maintaining a boot of a snow surf board
JP2007508290A (en) * 2003-10-10 2007-04-05 ファイザー・プロダクツ・インク Substituted 2H- [1,2,4] triazolo [4,3-a] pyrazine as a GSK-3 inhibitor

Also Published As

Publication number Publication date
FR2025779B1 (en) 1973-07-13
ZA697733B (en) 1971-06-30
BE742880A (en) 1970-06-09
IL33328A (en) 1972-08-30
GB1235910A (en) 1971-06-16
IL33328A0 (en) 1970-01-29
NL6916914A (en) 1970-06-12
FR2025779A1 (en) 1970-09-11
IE33837L (en) 1970-06-10
IE33837B1 (en) 1974-11-13
DE1961967A1 (en) 1970-06-25

Similar Documents

Publication Publication Date Title
IL29888A (en) Insecticidal and acaricidal compositions containing n-substituted 2,4,5-trihalo-imidazole derivatives
CA948109A (en) Pharmaceutical compositions containing 2-(t-butylamino)-1-((4-hydroxy-3-hydroxymethyl)phenyl)ethanol and a 6,8-dialkyl-s-triazolo(4,3-a)pyrazine
AU3701671A (en) Pharmaceutical formulations
AU471022B2 (en) Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione
CA954044A (en) Pharmaceutical composition containing fluoroalkylsilicon compounds
CA943462A (en) Pharmaceutical compositions containing 2-(2,6-dichlorophenyl-amino)-1,3-diazacyclopentene-(2)
CA961045A (en) 1-(1,3,-4-thiadiazol-2-yl)-imidazolidinone-(2) derivatives
CA974882A (en) ANALGESIC COMPOSITIONS CONTAINING .alpha.-D-PROPOXYPHENE AND CHLORDIAZEPOXIDE
CA847250A (en) Weed killing compositions and use thereof
CA883254A (en) Pharmaceutical compositions comprising 1-(2-methoxyphenoxy)-3-isopropylamino-2-propanol
CA950914A (en) 5-(substituted phenyl)-5-hydroxy-2,3-dihydro-5h-imidazo (2,1-a)isoindole
CA801756A (en) 1-(1'-phenyl-propyl-(3'))-4-carbalkoxy-piperidines
AU1513666A (en) 1-(4-substituted phenyl)-1-(4'substituted phenyl) 2-chlorocyclopropanes
CA812762A (en) Hypoglycemic compositions containing 3,5-disubstituted pyrazoles
AU427625B2 (en) Thiophosphates, thiophosphonates and insecticidal and acaricidal compositions containing the same
CA789002A (en) Antimicrobial preparations containing n-acyl-3,4-dihydro-oxazines-(1,3)
CA822642A (en) Pharmaceutical compositions containing 2,6-dichloro-benzene compounds
CA763931A (en) COMPOSITIONS CONTAINING 6.alpha.-METHYLPREDNISOLONE
AU435614B2 (en) Anti-seborrhoeic compositions suitable for oral administration
AU427106B2 (en) Novel pharmaceutical compositions containing polyvinylpyrrolidone
CA797800A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1-METHYLISATIN .beta.-THIOSEMICARBAZONE
CA801709A (en) Pharmaceutical compositions containing 2-(2'-naphthyl)-benzimidazoles
CA793809A (en) Safeguarded composition containing physiologically active ingredient
AU4720468A (en) Thiophosphates, thiophosphonates and insecticidal and acaricidal compositions containing the same
AU3396168A (en) Anti-seborrhoeic compositions suitable for oral administration